HK1215792A1 - Bakuchiol compositions for treatment of post inflammatory hyperpigmentation - Google Patents

Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Info

Publication number
HK1215792A1
HK1215792A1 HK16103749.0A HK16103749A HK1215792A1 HK 1215792 A1 HK1215792 A1 HK 1215792A1 HK 16103749 A HK16103749 A HK 16103749A HK 1215792 A1 HK1215792 A1 HK 1215792A1
Authority
HK
Hong Kong
Prior art keywords
treatment
inflammatory hyperpigmentation
post inflammatory
bakuchiol compositions
bakuchiol
Prior art date
Application number
HK16103749.0A
Other languages
Chinese (zh)
Inventor
洪梅芬
賈琦
利迪亞.阿爾法洛.布朗奈爾
Original Assignee
Unigen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigen Inc filed Critical Unigen Inc
Publication of HK1215792A1 publication Critical patent/HK1215792A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16103749.0A 2011-02-02 2016-04-01 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation HK1215792A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161438890P 2011-02-02 2011-02-02
PCT/US2011/026594 WO2012105990A1 (en) 2011-02-02 2011-03-01 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Publications (1)

Publication Number Publication Date
HK1215792A1 true HK1215792A1 (en) 2016-09-15

Family

ID=46603028

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103749.0A HK1215792A1 (en) 2011-02-02 2016-04-01 Bakuchiol compositions for treatment of post inflammatory hyperpigmentation

Country Status (8)

Country Link
KR (5) KR101954118B1 (en)
CN (2) CN105147533B (en)
AU (1) AU2012212153B9 (en)
BR (1) BR112013019798A2 (en)
CA (4) CA3128715A1 (en)
HK (1) HK1215792A1 (en)
MX (1) MX350719B (en)
WO (1) WO2012105990A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10471035B2 (en) 2014-10-20 2019-11-12 Sunny BioDiscovery Compositions and methods for using esters of meroterpenes and of other resveratrol analogues
CN105675741A (en) * 2015-12-30 2016-06-15 成都九芝堂金鼎药业有限公司 Method for determining content of effective components in hair growing pill
KR20190116858A (en) 2018-04-05 2019-10-15 주식회사 엑소코바이오 A composition comprising an exosome and/or extracellular vesicle derived from stem cell as an active ingredient and its application for preventing, alleviating, reducing or removing postinflammatory hyperpigmentation
CN111544317B (en) * 2020-04-29 2022-01-14 珀莱雅化妆品股份有限公司 Anti-aging composition cationic nano-liposome and preparation method and application thereof
CN114478196B (en) * 2021-01-27 2023-11-10 江苏巴帝恩生物科技有限公司 Method for extracting and purifying bakuchiol from Ulmus pumila root and application of bakuchiol in cosmetics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617473B2 (en) 1987-06-30 1997-06-04 キヤノン株式会社 Information input device
BRPI0608796B8 (en) * 2005-05-09 2021-05-25 Unigen Pharmaceuticals Inc method for preparing a plant extract comprising bacuquiol
WO2008140673A1 (en) * 2007-05-14 2008-11-20 Sytheon Ltd. Skin treatment compositions and methods

Also Published As

Publication number Publication date
CA2826262A1 (en) 2012-08-09
CN103458882A (en) 2013-12-18
MX350719B (en) 2017-09-14
CA3128718A1 (en) 2012-08-09
KR102156731B1 (en) 2020-09-16
CA2826262C (en) 2021-10-26
MX2013008890A (en) 2013-10-17
KR102642352B1 (en) 2024-02-28
CA3128711A1 (en) 2012-08-09
KR20200108120A (en) 2020-09-16
AU2012212153B2 (en) 2017-04-06
KR20190025740A (en) 2019-03-11
CN105147533A (en) 2015-12-16
AU2012212153B9 (en) 2017-05-11
AU2012212153A1 (en) 2013-08-29
BR112013019798A2 (en) 2017-07-04
KR20210145864A (en) 2021-12-02
WO2012105990A1 (en) 2012-08-09
CN105147533B (en) 2018-07-31
KR102333655B1 (en) 2021-12-01
CN103458882B (en) 2015-08-05
KR102525516B1 (en) 2023-04-24
CA3128715A1 (en) 2012-08-09
KR20140008364A (en) 2014-01-21
KR20230058727A (en) 2023-05-03
KR101954118B1 (en) 2019-03-05

Similar Documents

Publication Publication Date Title
EP2717926A4 (en) Compositions and methods to prevent and treat biofilms
EP2712362A4 (en) Manufacture of lacto-n-tetraose
IL229830B (en) Novel compinds as modulatord of gpr-119
EP2723384A4 (en) Treatment of proteinopathies
EP2554175A4 (en) Composition for treatment of damaged part
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
EP2766390A4 (en) Compositions and methods for treating heart failure
HK1190936A1 (en) Methods and compositions for treating metabolic syndrome
HK1199015A1 (en) Treatment of inflammation
ZA201404482B (en) Seed treatment composition
IL228630A0 (en) Compounds for treatment of metabolic syndrome
HRP20180567T1 (en) Pharmaceutical composition of omeprazole
HK1215792A1 (en) Bakuchiol compositions for treatment of post inflammatory hyperpigmentation
IL231622B (en) Pharmaceutical composition for treatment of cachexia
PT2739276T (en) Antiseptic composition
EP2763756A4 (en) Bromofluorocarbon compositions
EP2727586A4 (en) Soyasapogenol composition
EP2768481A4 (en) Compositions for reduction of side effects
ZA201401847B (en) Cleansing composition
HK1177432A1 (en) Composition for amelioration of hypoalbuminemia
EP2718427A4 (en) Compositions and methods for glioblastoma treatment
HK1199818A1 (en) Treatment of seborrhoea
GB201115652D0 (en) Water stable form of glutamine
IL213610A0 (en) Composition for treating dermatological conditions
GB201100651D0 (en) Treatment of inflammation